When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - European advisory group backs Celgene's ozanimod for type of multiple sclerosis
Bristol-Myers Squibb Company
The European Medicines Agency's advisory group CHMP has adopted a positive opinion recommending approval of Celgene's (CELG) Zeposia (ozanimod) for the treatment of adults with relapsing remitting multiple sclerosis with active disease.
More news on: Celgene Corporation, Bristol-Myers Squibb Company, Healthcare stocks news,